Cargando…
P1088: UPDATED DATA FROM A PHASE 1/2 STUDY OF BRENTUXIMAB VEDOTIN COMBINED WITH CHEMOTHERAPY IN PEDIATRIC PATIENTS WITH ADVANCED STAGE CLASSICAL HODGKIN LYMPHOMA
| Autores principales: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429058/ http://dx.doi.org/10.1097/01.HS9.0000847220.98181.15 |
| _version_ | 1784779314596675584 |
|---|---|
| author | Locatelli, F. Luisi, F. Pianovski, M. Salvino, M. A. Fagioli, F. Epelman, S. Britto De Abreu Lima, L. Norris, R. Odone Filho, V. Zecca, M. Favre, C. Kobayashi, R. Koga, Y. Sidi, Y. Zhou, X. Bai, X. Campana, F. Leonard, E. J. Franklin, A. R. |
| author_facet | Locatelli, F. Luisi, F. Pianovski, M. Salvino, M. A. Fagioli, F. Epelman, S. Britto De Abreu Lima, L. Norris, R. Odone Filho, V. Zecca, M. Favre, C. Kobayashi, R. Koga, Y. Sidi, Y. Zhou, X. Bai, X. Campana, F. Leonard, E. J. Franklin, A. R. |
| author_sort | Locatelli, F. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9429058 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94290582022-08-31 P1088: UPDATED DATA FROM A PHASE 1/2 STUDY OF BRENTUXIMAB VEDOTIN COMBINED WITH CHEMOTHERAPY IN PEDIATRIC PATIENTS WITH ADVANCED STAGE CLASSICAL HODGKIN LYMPHOMA Locatelli, F. Luisi, F. Pianovski, M. Salvino, M. A. Fagioli, F. Epelman, S. Britto De Abreu Lima, L. Norris, R. Odone Filho, V. Zecca, M. Favre, C. Kobayashi, R. Koga, Y. Sidi, Y. Zhou, X. Bai, X. Campana, F. Leonard, E. J. Franklin, A. R. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9429058/ http://dx.doi.org/10.1097/01.HS9.0000847220.98181.15 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Locatelli, F. Luisi, F. Pianovski, M. Salvino, M. A. Fagioli, F. Epelman, S. Britto De Abreu Lima, L. Norris, R. Odone Filho, V. Zecca, M. Favre, C. Kobayashi, R. Koga, Y. Sidi, Y. Zhou, X. Bai, X. Campana, F. Leonard, E. J. Franklin, A. R. P1088: UPDATED DATA FROM A PHASE 1/2 STUDY OF BRENTUXIMAB VEDOTIN COMBINED WITH CHEMOTHERAPY IN PEDIATRIC PATIENTS WITH ADVANCED STAGE CLASSICAL HODGKIN LYMPHOMA |
| title | P1088: UPDATED DATA FROM A PHASE 1/2 STUDY OF BRENTUXIMAB VEDOTIN COMBINED WITH CHEMOTHERAPY IN PEDIATRIC PATIENTS WITH ADVANCED STAGE CLASSICAL HODGKIN LYMPHOMA |
| title_full | P1088: UPDATED DATA FROM A PHASE 1/2 STUDY OF BRENTUXIMAB VEDOTIN COMBINED WITH CHEMOTHERAPY IN PEDIATRIC PATIENTS WITH ADVANCED STAGE CLASSICAL HODGKIN LYMPHOMA |
| title_fullStr | P1088: UPDATED DATA FROM A PHASE 1/2 STUDY OF BRENTUXIMAB VEDOTIN COMBINED WITH CHEMOTHERAPY IN PEDIATRIC PATIENTS WITH ADVANCED STAGE CLASSICAL HODGKIN LYMPHOMA |
| title_full_unstemmed | P1088: UPDATED DATA FROM A PHASE 1/2 STUDY OF BRENTUXIMAB VEDOTIN COMBINED WITH CHEMOTHERAPY IN PEDIATRIC PATIENTS WITH ADVANCED STAGE CLASSICAL HODGKIN LYMPHOMA |
| title_short | P1088: UPDATED DATA FROM A PHASE 1/2 STUDY OF BRENTUXIMAB VEDOTIN COMBINED WITH CHEMOTHERAPY IN PEDIATRIC PATIENTS WITH ADVANCED STAGE CLASSICAL HODGKIN LYMPHOMA |
| title_sort | p1088: updated data from a phase 1/2 study of brentuximab vedotin combined with chemotherapy in pediatric patients with advanced stage classical hodgkin lymphoma |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429058/ http://dx.doi.org/10.1097/01.HS9.0000847220.98181.15 |
| work_keys_str_mv | AT locatellif p1088updateddatafromaphase12studyofbrentuximabvedotincombinedwithchemotherapyinpediatricpatientswithadvancedstageclassicalhodgkinlymphoma AT luisif p1088updateddatafromaphase12studyofbrentuximabvedotincombinedwithchemotherapyinpediatricpatientswithadvancedstageclassicalhodgkinlymphoma AT pianovskim p1088updateddatafromaphase12studyofbrentuximabvedotincombinedwithchemotherapyinpediatricpatientswithadvancedstageclassicalhodgkinlymphoma AT salvinoma p1088updateddatafromaphase12studyofbrentuximabvedotincombinedwithchemotherapyinpediatricpatientswithadvancedstageclassicalhodgkinlymphoma AT fagiolif p1088updateddatafromaphase12studyofbrentuximabvedotincombinedwithchemotherapyinpediatricpatientswithadvancedstageclassicalhodgkinlymphoma AT epelmans p1088updateddatafromaphase12studyofbrentuximabvedotincombinedwithchemotherapyinpediatricpatientswithadvancedstageclassicalhodgkinlymphoma AT brittodeabreulimal p1088updateddatafromaphase12studyofbrentuximabvedotincombinedwithchemotherapyinpediatricpatientswithadvancedstageclassicalhodgkinlymphoma AT norrisr p1088updateddatafromaphase12studyofbrentuximabvedotincombinedwithchemotherapyinpediatricpatientswithadvancedstageclassicalhodgkinlymphoma AT odonefilhov p1088updateddatafromaphase12studyofbrentuximabvedotincombinedwithchemotherapyinpediatricpatientswithadvancedstageclassicalhodgkinlymphoma AT zeccam p1088updateddatafromaphase12studyofbrentuximabvedotincombinedwithchemotherapyinpediatricpatientswithadvancedstageclassicalhodgkinlymphoma AT favrec p1088updateddatafromaphase12studyofbrentuximabvedotincombinedwithchemotherapyinpediatricpatientswithadvancedstageclassicalhodgkinlymphoma AT kobayashir p1088updateddatafromaphase12studyofbrentuximabvedotincombinedwithchemotherapyinpediatricpatientswithadvancedstageclassicalhodgkinlymphoma AT kogay p1088updateddatafromaphase12studyofbrentuximabvedotincombinedwithchemotherapyinpediatricpatientswithadvancedstageclassicalhodgkinlymphoma AT sidiy p1088updateddatafromaphase12studyofbrentuximabvedotincombinedwithchemotherapyinpediatricpatientswithadvancedstageclassicalhodgkinlymphoma AT zhoux p1088updateddatafromaphase12studyofbrentuximabvedotincombinedwithchemotherapyinpediatricpatientswithadvancedstageclassicalhodgkinlymphoma AT baix p1088updateddatafromaphase12studyofbrentuximabvedotincombinedwithchemotherapyinpediatricpatientswithadvancedstageclassicalhodgkinlymphoma AT campanaf p1088updateddatafromaphase12studyofbrentuximabvedotincombinedwithchemotherapyinpediatricpatientswithadvancedstageclassicalhodgkinlymphoma AT leonardej p1088updateddatafromaphase12studyofbrentuximabvedotincombinedwithchemotherapyinpediatricpatientswithadvancedstageclassicalhodgkinlymphoma AT franklinar p1088updateddatafromaphase12studyofbrentuximabvedotincombinedwithchemotherapyinpediatricpatientswithadvancedstageclassicalhodgkinlymphoma |